Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jun 7;20(11):2796.
doi: 10.3390/ijms20112796.

Application of Periodontal Ligament-Derived Multipotent Mesenchymal Stromal Cell Sheets for Periodontal Regeneration

Affiliations
Review

Application of Periodontal Ligament-Derived Multipotent Mesenchymal Stromal Cell Sheets for Periodontal Regeneration

Satoru Onizuka et al. Int J Mol Sci. .

Abstract

Periodontitis is a chronic inflammatory disorder that causes destruction of the periodontal attachment apparatus including alveolar bone, the periodontal ligament, and cementum. Dental implants have been routinely installed after extraction of periodontitis-affected teeth; however, recent studies have indicated that many dental implants are affected by peri-implantitis, which progresses rapidly because of the failure of the immune system. Therefore, there is a renewed focus on periodontal regeneration aroundnatural teeth. To regenerate periodontal tissue, many researchers and clinicians have attempted to perform periodontal regenerative therapy using materials such as bioresorbable scaffolds, growth factors, and cells. The concept of guided tissue regeneration, by which endogenous periodontal ligament- and alveolar bone-derived cells are preferentially proliferated by barrier membranes, has proved effective, and various kinds of membranes are now commercially available. Clinical studies have shown the significance of barrier membranes for periodontal regeneration; however, the technique is indicated only for relatively small infrabony defects. Cytokine therapies have also been introduced to promote periodontal regeneration, but the indications are also for small size defects. To overcome this limitation, ex vivo expanded multipotent mesenchymal stromal cells (MSCs) have been studied. In particular, periodontal ligament-derived multipotent mesenchymal stromal cells are thought to be a responsible cell source, based on both translational and clinical studies. In this review, responsible cell sources for periodontal regeneration and their clinical applications are summarized. In addition, recent transplantation strategies and perspectives about the cytotherapeutic use of stem cells for periodontal regeneration are discussed.

Keywords: MSCs; clinical study; periodontal ligament; periodontal regeneration; stem cells.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Typical clinical appearance after conventional periodontal treatment. Black triangles appear because of the gingival recessions, resulting in both functional and aesthetic problems. Gingival recessions occurred in all dentitions, resulting in hypersensitivity and root caries.
Figure 2
Figure 2
Classification of periodontal bony defects and materials for periodontal regeneration. Conventional regenerative therapies including bone graft materials, protein products, and barrier membrane can be applied to only small size defects such as three-wall defects, two-wall defects, and class II furcation defects.

Similar articles

Cited by

References

    1. Pihlstrom B.L., Michalowicz B.S., Johnson N.W. Periodontal diseases. Lancet. 2005;366:1809–1820. doi: 10.1016/S0140-6736(05)67728-8. - DOI - PubMed
    1. Hegedus Z. The rebuilding of the alveolar processes by bone transplantation. Dent. Cosmos. 1923;65:736–742.
    1. Sculean A., Nikolidakis D., Nikou G., Ivanovic A., Chapple I.L., Stavropoulos A. Biomaterials for promoting periodontal regeneration in human intrabony defects: A systematic review. Periodontol 2000. 2015;68:182–216. doi: 10.1111/prd.12086. - DOI - PubMed
    1. Bartold P.M., Gronthos S., Ivanovski S., Fisher A., Hutmacher D.W. Tissue engineered periodontal products. J. Periodontal Res. 2016;51:1–15. doi: 10.1111/jre.12275. - DOI - PubMed
    1. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., Deans R., Keating A., Prockop D., Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315–317. doi: 10.1080/14653240600855905. - DOI - PubMed

MeSH terms

LinkOut - more resources